Alamar Biosciences Inc. (ALMR)
NASDAQ: ALMRHealthcareMedical DevicesUSD
Market open · Delayed 15 min · as of Oct 7, 3:27 PM ET
ALMR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.98B
- EPS (TTM)
- -$1.20
- Dividend yield
- None
- 52-week range
- 18.85 – 39.61
- Day range
- 28.00 – 32.02
- Volume / Avg
- 799.11K / 383.88K
- Beta
- —
- Shares outstanding
- 69.39M
52-week range
ALMR stock today
Shares of Alamar Biosciences (ALMR) are trading lower on Oct 7 at $28.59, a drop of 11.41% or $3.67 per share, versus the S&P 500's 0.25% decline. Volume was 2.1x the average at 799.11K shares, a sign of unusually heavy trading. At this level, ALMR sits in the middle of its 52-week range of $18.85 to $39.61: 27.8% below the high and 51.7% above the low.
Alamar Biosciences has posted a net loss over the last twelve months (EPS of -$1.20), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Alamar Biosciences
Company profileAlamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Dr. Yuling Luo Ph.D.
- Headquarters
- Fremont, CA
- Employees
- 286
- IPO year
- 2026
- Website
- alamarbio.com
Analyst forecast
ForecastConsensus (5 analysts)
buy
Avg. price target
$35.40+23.82%
- Strong buy 1
- Buy 3
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Alamar Biosciences peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| UFPTUFP Technologies Inc. | 293.64 | -3.05% | $2.27B | vs ALMR |
| BFLYButterfly Network Inc. Class A | 8.19 | -5.92% | $2.18B | vs ALMR |
| AXGNAxogen Inc. | 36.26 | -0.14% | $2.13B | vs ALMR |
| INSPInspire Medical Systems Inc. | 67.45 | -1.10% | $1.95B | vs ALMR |
| NEOGNeogen Corporation | 11.63 | -2.76% | $2.54B | vs ALMR |
| ESTAEstablishment Labs Holdings Inc. | 64.10 | -1.82% | $1.91B | vs ALMR |
| NVCRNovoCure Limited | 14.69 | -1.90% | $1.71B | vs ALMR |
| TMDXTransMedics Group Inc. | 82.19 | +2.37% | $2.85B | vs ALMR |
Indexes, lists and sector
Appears in lists
Alamar Biosciences stock FAQ
What is Alamar Biosciences's stock price today?
ALMR last traded at $28.59 as of Oct 7, 3:27 PM EDT, down 11.41% on the day. Prices are delayed at least 15 minutes.
Who is Alamar Biosciences's CEO?
Dr. Yuling Luo Ph.D. is the chief executive officer of Alamar Biosciences Inc., which has about 286 employees.
What is the ALMR 52-week high?
The 52-week high for ALMR is $39.61 and the 52-week low is $18.85. The stock is currently 27.8% below its high.